Penelope D. Ottewell

4.1k total citations · 1 hit paper
72 papers, 3.1k citations indexed

About

Penelope D. Ottewell is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Penelope D. Ottewell has authored 72 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 29 papers in Molecular Biology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Penelope D. Ottewell's work include Bone health and treatments (38 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Bone Metabolism and Diseases (14 papers). Penelope D. Ottewell is often cited by papers focused on Bone health and treatments (38 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Bone Metabolism and Diseases (14 papers). Penelope D. Ottewell collaborates with scholars based in United Kingdom, United States and Australia. Penelope D. Ottewell's co-authors include Ingunn Holen, Diane V. Lefley, Robert E. Coleman, Claudia Tulotta, Hannah K. Brown, Ning Wang, Rob Coleman, Colby L. Eaton, Alastair J.M. Watson and Peter I. Croucher and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Physiological Reviews.

In The Last Decade

Penelope D. Ottewell

70 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone metastasis: mechanisms, therapies, and biomarkers

2020 243 citations Philippe Clézardin, Margherita Puppo et al. profile →

Peers

Countries citing papers authored by Penelope D. Ottewell

Since Specialization

Citations

This map shows the geographic impact of Penelope D. Ottewell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope D. Ottewell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope D. Ottewell more than expected).

Fields of papers citing papers by Penelope D. Ottewell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penelope D. Ottewell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope D. Ottewell. The network helps show where Penelope D. Ottewell may publish in the future.

Co-authorship network of co-authors of Penelope D. Ottewell

This figure shows the co-authorship network connecting the top 25 collaborators of Penelope D. Ottewell. A scholar is included among the top collaborators of Penelope D. Ottewell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penelope D. Ottewell. Penelope D. Ottewell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis 2024 ·Breast Cancer Research ·Margherita Puppo, Martine Croset, Davide Ceresa, Manoj K. Valluru, (unknown), (unknown), Michele Iuliani, Francesco Pantano, Penelope D. Ottewell, Philippe Clézardin	1
2	The role of IL-1B in breast cancer bone metastasis 2024 ·Journal of bone oncology ·(unknown), Penelope D. Ottewell	7
3	IL-1β in breast cancer bone metastasis 2022 ·Expert Reviews in Molecular Medicine ·(unknown), Claudia Tulotta, Penelope D. Ottewell	23
4	IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer 2021 ·npj Breast Cancer ·Claudia Tulotta, Diane V. Lefley, (unknown), (unknown), (unknown), (unknown), Russell Hughes, (unknown), Victoria Cookson, Catherine A. Evans, Jayakumar Vadakekolathu, Paul R. Heath, (unknown), Emmanuel Pinteaux, A. Graham Pockley, Penelope D. Ottewell	38
5	Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions 2020 ·Journal of bone oncology ·(unknown), (unknown), (unknown), Munitta Muthana, Caroline Wilson, Penelope D. Ottewell	21
6	Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment 2019 ·Clinical Cancer Research ·Claudia Tulotta, Diane V. Lefley, (unknown), Walter M. Gregory, Andrew M. Hanby, Paul R. Heath, Faith Nutter, J. Mark Wilkinson, (unknown), Xinming Liu, Steven M.J. Bradbury, (unknown), Victoria Cookson, (unknown), Marianna Kruithof‐de Julio, Robert E. Coleman, Janet E. Brown, Ingunn Holen, Penelope D. Ottewell	136
7	Animal Models of Breast Cancer Bone Metastasis 2019 ·Methods in molecular biology ·Claudia Tulotta, Arwin Groenewoud, B. Ewa Snaar‐Jagalska, Penelope D. Ottewell	14
8	The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo 2019 ·Journal of bone oncology ·(unknown), Russell Hughes, Ning Wang, Hannah K. Brown, Penelope D. Ottewell, Nicola J. Brown, Ingunn Holen	57
9	Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer 2019 ·Cancer Letters ·Ryan T. Bishop, Silvia Marino, (unknown), (unknown), Diane V. Lefley, Andrew H. Sims, Ning Wang, Penelope D. Ottewell, Aymen I. Idris	19
10	The IL‐1/IL‐1R axis induces greater fibroblast‐derived chemokine release in human papillomavirus‐negative compared to positive oropharyngeal cancer 2018 ·International Journal of Cancer ·(unknown), Keith D. Hunter, Robert Bolt, Penelope D. Ottewell, Craig Murdoch	15
11	Murine models of breast cancer bone metastasis 2016 ·BoneKEy Reports ·Laura E. Wright, Penelope D. Ottewell, Nadia Rucci, Olivier Peyruchaud, Gabriel M. Pagnotti, Antonella Chiechi, Jeroen T. Buijs, Julie A. Sterling	84
12	The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer 2015 ·Journal of Experimental & Clinical Cancer Research ·Ning Wang, Kimberley J. Reeves, Hannah K. Brown, (unknown), (unknown), Penelope D. Ottewell, Peter I. Croucher, Ingunn Holen, Colby L. Eaton	46
13	Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer 2015 ·Current Cancer Drug Targets ·(unknown), Penelope D. Ottewell, Ingunn Holen	31
14	Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo 2014 ·Clinical Cancer Research ·Penelope D. Ottewell, Ning Wang, Hannah K. Brown, (unknown), (unknown), Peter I. Croucher, Colby L. Eaton, Ingunn Holen	131
15	Combined Therapies of Bone Disease with Bisphosphonates 2010 ·Current Pharmaceutical Design ·(unknown), Penelope D. Ottewell, Ingunn Holen	9
16	The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells 2009 ·Journal of Cellular and Molecular Medicine ·Hannah K. Brown, Penelope D. Ottewell, Robert E. Coleman, Ingunn Holen	25
17	Gastrin Increases Murine Intestinal Crypt Regeneration Following Injury 2006 ·Gastroenterology ·Penelope D. Ottewell, Carrie A. Duckworth, Andrea Varró, R. Dimaline, Timothy C. Wang, Alastair J.M. Watson, Graham J. Dockray, D. Mark Pritchard	20
18	Imaging apoptosis in vivo using 124I-annexin V and PET 2005 ·Nuclear Medicine and Biology ·(unknown), (unknown), (unknown), D. L. Hastings, (unknown), Andrew J. Reader, Penelope D. Ottewell, Alastair J.M. Watson, Jamal Zweit	76
19	MBP–annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET 2005 ·Nuclear Medicine and Biology ·(unknown), (unknown), (unknown), (unknown), D. L. Hastings, Andrew J. Reader, Penelope D. Ottewell, Alastair J.M. Watson, Jamal Zweit	29
20	From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies 2005 ·Breast Cancer Research and Treatment ·Penelope D. Ottewell, Robert E. Coleman, Ingunn Holen	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact